A single-center, randomized, double-blind, placebo-controlled, cross-over study of intranasal oxytocin in young adults with Autism Spectrum Disorder Studio monocentrico, cross-over, randomizzato, in doppio cieco, controllato con placebo, sulla somministrazione intranasale di ossitocina in giovani adulti con disturbi dello spettro autistico.
Latest Information Update: 12 Aug 2021
At a glance
- Drugs Oxytocin (Primary)
- Indications Autistic disorder
- Focus Adverse reactions
- 12 Aug 2021 New trial record